Organigram (TSE:OGI) Stock Price Down 0.4% – Here’s What Happened

Organigram Holdings Inc. (TSE:OGI) fell 0.4% on Friday . The company traded as low as C$2.37 and last traded at C$2.38. 95,488 shares traded hands during trading, a decline of 69% from the average session volume of 309,231 shares. The stock had previously closed at C$2.39.

Analysts Set New Price Targets

Separately, Canaccord Genuity Group raised their price objective on Organigram from C$3.25 to C$3.60 and gave the stock a “speculative buy” rating in a research report on Wednesday, August 14th.

Organigram Trading Down 0.4 %

The company has a fifty day simple moving average of C$2.42 and a two-hundred day simple moving average of C$2.48. The company has a current ratio of 6.95, a quick ratio of 2.62 and a debt-to-equity ratio of 1.13. The company has a market cap of C$258.40 million, a PE ratio of -0.95, a P/E/G ratio of 0.42 and a beta of 1.13.

Organigram (TSE:OGI) last released its earnings results on Tuesday, August 13th. The company reported C$0.03 earnings per share for the quarter, topping analysts’ consensus estimates of C($0.07) by C$0.10. Organigram had a negative net margin of 153.80% and a negative return on equity of 54.53%. The firm had revenue of C$41.06 million for the quarter, compared to analyst estimates of C$39.20 million. Analysts anticipate that Organigram Holdings Inc. will post 0.1639232 EPS for the current year.

Insider Transactions at Organigram

In other news, Senior Officer Paolo De Luca sold 13,835 shares of the company’s stock in a transaction dated Wednesday, September 11th. The stock was sold at an average price of C$2.54, for a total transaction of C$35,140.90. Following the completion of the transaction, the insider now directly owns 625 shares of the company’s stock, valued at approximately C$1,587.50. This represents a 0.00 % decrease in their position. Corporate insiders own 31.32% of the company’s stock.

Organigram Company Profile

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED’ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.